Jane Street Group, LLC Standard Biotools Inc. Call Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 15, 2022	SELL	$3.63 - $6.13 $30,492 - $51,492	-8,400 Reduced 27.45%	22,200 $87,000
Q3 2021 Nov 16, 2021	SELL	$5.5 - $7.41 $50,600 - $68,172	-9,200 Reduced 23.12%	30,600 $202,000
Q2 2021 Aug 16, 2021	SELL	$4.35 - $6.35 $87,435 - $127,635	-20,100 Reduced 33.56%	39,800 $245,000
Q1 2021 May 18, 2021	SELL	$3.94 - $7.09 $88,256 - $158,816	-22,400 Reduced 27.22%	59,900 $271,000
Q4 2020 Feb 17, 2021	SELL	$5.45 - $8.65 $1.8 Million - $2.85 Million	-329,900 Reduced 80.03%	82,300 $494,000
Q3 2020 Nov 17, 2020	BUY	$4.34 - $11.43 $1.79 Million - $4.71 Million	412,200 New	412,200 $3.06 Million

143

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $132M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.